| Literature DB >> 31851223 |
Ana Carolina Cavalcante Viana1, Fernanda Maria Machado Maia2, Natália Sales de Carvalho3, Suelyne Rodrigues de Morais2, Alane Nogueira Bezerra4, Priscila da Silva Mendonça1, Sâmia Lopes da Costa2, Ana Filomena Camacho Santos Daltro1.
Abstract
OBJECTIVE: To evaluate the oxidative profile, nutritional status and food intake (caloric value; macronutrients; vitamins A, E and C; and zinc), and to correlate oxidative stress with nutritional status in patients who were candidates for liver transplant.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31851223 PMCID: PMC6905167 DOI: 10.31744/einstein_journal/2020AO4039
Source DB: PubMed Journal: Einstein (Sao Paulo) ISSN: 1679-4508
Sociodemographic and clinical variables of pre-liver transplant patients
| Variables | Population | Mean±SD |
|---|---|---|
| n (%) | ||
| Age, years | 49.17±8.17 | |
| Male sex | 31 (60.78) | |
| Level of schooling | ||
| None | 2 (3.92) | |
| Elementary or Middle School | 41(80.39) | |
| Higher education | 8 (15.69) | |
| MELD | 18.72±4.02 | |
| Child-Pugh* | ||
| A | 8 (15.69) | |
| B | 29 (56.86) | |
| C | 11 (21.57) | |
| Comorbidities (DM and/or HTN) | 20 (39.22) |
* Three (5%) individuals did not present with established Child-Pugh. SD: standard deviation; MELD: Model for End-Stage Liver Disease; DM: diabetes mellitus ; HTN: hypertension.
Diagnoses of pre-liver transplant patients
| Diagnosis | Individuals with respective diagnosis |
|---|---|
| Alcoholic cirrhosis | 17 (33.33) |
| Cirrhosis due to viral hepatites | 16 (31.37) |
| Cryptogenic cirrhosis | 8 (15.69) |
| Cholestatic cirrhosis and/or autoimmune hepatitis | 3 (5.88) |
| Budd-Chiari syndrome | 3 (5.88) |
| Cirrhosis and neuroendocrine tumor | 1 (1.96) |
| Non-alcoholic steatohepatitis | 1 (1.96) |
| Niemann-Pick | 1 (1.96) |
| Retransplant due to rejection and cirrhosis | 1 (1.96) |
Result expressed as n (%).
Classification of the nutritional status of pre-liver transplant patients
| Classification of nutritional status | BMI-Campillo | AC | TSF | AMC |
|---|---|---|---|---|
| Malnutrition | 16 (31.37) | 27 (52.94) | 26 (50.98) | 29 (56.86) |
| Eutrophia | 35 (68.63) | 17 (33.33) | 5 (9.80) | 22 (43.14) |
| Overweight | 3 (5.88) | 1 (1.96) | 0 (0.00) | |
| Obesity | 4 (7.84) | 19 (37.25) | 0 (0.00) |
Result expressed as n (%). BMI: body mass index; AC: arm circumference; TSF: triceps skinfold; AMC: arm muscle circumference.
Analysis of calorie consumption adequacy; carbohydrate; protein; lipid; vitamins A, E, and C; and zinc of pre-liver transplant patients, as per recommendation
| Calories and nutrients | Consumption | Below | Adequate | Above |
|---|---|---|---|---|
| EC, kg/IW | 31.00±11.41 | 34 (66.67) | 8 (15.69) | 9 (17.65) |
| Proteins, (g)/kg/IW | 1.23±0.50 | 29 (56.86) | 14 (27.45) | 8 (15.69) |
| Carbohydrates, % | 60.49±7.78 | 45 (88.24) | 5 (9.80) | 1 (1.96) |
| Lipids, % | 24.47±6.34 | 12 (23.53) | 30 (58.82) | 9 (17.65) |
| Vitamin A, mcg | 1,010.64± 2,042.66 | 39 (76.47) | 8 (15.69) | 4 (7.84) |
| Vitamin E, mg | 5.21±3.43 | 51 (100.00) | 0 (0.00) | 0 (0.00) |
| Vitamin C, mg | 409.66±672.24 | 11(21.57) | 35 (68.63) | 5 (9.80) |
| Zinc, mg | 7.20±3.93 | |||
| Qualitative analysis | 41 (80.39) | 10 (19.61) | 0 (0.00) | |
| Quantitative analysis | 18 (35.29) | 33 (64.71) |
Result expressed as mean±standard deviation and n (%); EC: energy consumption; IW: ideal weight.
Figure 1Correlation (Spearman’s test) of malondialdehyde and body mass index of pre-liver transplant patients
BMI: body mass index; MDA: malondialdehyde.
Variáveis sociodemográficas e clínicas de pacientes pré-transplante hepático
| Variáveis | População | Média±DP |
|---|---|---|
| n (%) | ||
| Idade, anos | 49,17±8,17 | |
| Sexo masculino | 31 (60,78) | |
| Escolaridade | ||
| Nenhuma | 2 (3,92) | |
| Ensino Fundamental ou Médio | 41(80,39) | |
| Ensino Superior | 8 (15,69) | |
| MELD | 18,72±4,02 | |
| Child-Pugh* | ||
| A | 8 (15,69) | |
| B | 29 (56,86) | |
| C | 11 (21,57) | |
| Comorbidades (DM e/ou HAS) | 20 (39,22) |
* Três (5%) indivíduos não apresentavam Child-Pugh estabelecido. DP: desvio padrão; MELD: Model for End-Stage Liver Disease ; DM: diabetes mellitus ; HAS: hipertensão arterial sistêmica.
Diagnósticos de pacientes pré-transplante hepático
| Diagnóstico | Indivíduos com respectivo diagnóstico |
|---|---|
| Cirrose alcóolica | 17 (33,33) |
| Cirrose por hepatites virais | 16 (31,37) |
| Cirrose criptogênica | 8 (15,69) |
| Cirrose colestática e/ou hepatite autoimune | 3 (5,88) |
| Síndrome de Budd-Chiari | 3 (5,88) |
| Cirrose e tumor neuroendócrino | 1 (1,96) |
| Esteato hepatite não alcóolica | 1 (1,96) |
| Niemann-Pick | 1 (1,96) |
| Retransplante por rejeição e cirrose | 1 (1,96) |
Resultado expresso por n (%).
Classificação do estado nutricional de pacientes pré-transplante hepático
| Classificação do estado nutricional | IMC-Campillo | CB | DCT | CMB |
|---|---|---|---|---|
| Desnutrição | 16 (31,37) | 27 (52,94) | 26 (50,98) | 29 (56,86) |
| Eutrofia | 35 (68,63) | 17 (33,33) | 5 (9,80) | 22 (43,14) |
| Sobrepeso | 3 (5,88) | 1 (1,96) | 0 (0,00) | |
| Obesidade | 4 (7,84) | 19 (37,25) | 0 (0,00) |
Resultado expresso por n (%). IMC: índice de massa corporal; CB: circunfência do braço; DCT: dobra cutânea triciptal; CMB: circunferência muscular do braço.
Análise da adequação do consumo calórico; carboidrato; proteína; lipídio; vitaminas A, E e C; e zinco de pacientes pré-transplante hepático, conforme recomendação
| Caloria e nutrientes | Consumo | Abaixo | Adequado | Acima |
|---|---|---|---|---|
| CE, kg/PI | 31,00±11,41 | 34 (66,67) | 8 (15,69) | 9 (17,65) |
| Proteína, (g)/kg/PI | 1,23±0,50 | 29 (56,86) | 14 (27,45) | 8 (15,69) |
| Carboidrato, % | 60,49±7,78 | 45 (88,24) | 5 (9,80) | 1 (1,96) |
| Lipídio, % | 24,47±6,34 | 12 (23,53) | 30 (58,82) | 9 (17,65) |
| Vitamina A, mcg | 1.010,64±2.042,66 | 39 (76,47) | 8 (15,69) | 4 (7,84) |
| Vitamina E, mg | 5,21±3,43 | 51 (100,00) | 0 (0,00) | 0 (0,00) |
| Vitamina C, mg | 409,66±672,24 | 11(21,57) | 35 (68,63) | 5 (9,80) |
| Zinco, mg | 7,20±3,93 | |||
| Análise qualitativa | 41 (80,39) | 10 (19,61) | 0 (0,00) | |
| Análise quantitativa | 18 (35,29) | 33 (64,71) |
Resultado expresso por média±desvio padrão e n (%); CE: consumo energético; PI: peso ideal.
Figura 1Correlação (teste de Spearman) do malondialdeído e índice de massa corporal dos pacientes pré-transplante hepático
IMC: índice de massa corporal; MDA: malondialdeído.